Obrecht Daniel, Altorfer Michael, Lehmann Christian, Schönholzer Peter, Müller Klaus
Pharma Research, F. Hoffmann-La Roche AG, CH-4070 Basel, Switzerland.
J Org Chem. 1996 Jun 14;61(12):4080-4086. doi: 10.1021/jo952068g.
A novel strategy for the synthesis of (R)- and (S)-alpha-methyl(alkyl)serine-containing peptides is presented. Using (S)-phenylalanine cyclohexylamide 6 as chiral auxiliary, the optically pure azlactones (R)- and (S)-2 were synthesized via a novel azlactone/oxazoline interconversion reaction (Figures 3 and 6). These azlactones constitute fully protected and activated synthetic equivalents of (R)- and (S)-alpha-methylserine and can be directly incorporated into peptides without further protective group manipulations. Like other alpha,alpha-dialkylated glycines, optically pure alpha-alkylserines can be used to stabilize beta-turn and alpha-helical conformations in short peptides.
本文提出了一种合成含(R)-和(S)-α-甲基(烷基)丝氨酸肽的新策略。以(S)-苯丙氨酸环己酰胺6作为手性助剂,通过一种新的恶唑酮/恶唑啉相互转化反应合成了光学纯的恶唑酮(R)-2和(S)-2(图3和图6)。这些恶唑酮构成了(R)-和(S)-α-甲基丝氨酸的完全保护且活化的合成等效物,可直接掺入肽中,无需进一步的保护基操作。与其他α,α-二烷基甘氨酸一样,光学纯的α-烷基丝氨酸可用于稳定短肽中的β-转角和α-螺旋构象。